Cytokine interaction and immune responses during schistosoma mansoni Infection

Parasitology Today

Volumn 14, Issue 10, 1998, Pages 422-427

  Brunet, L R ^a   Dunne, D W ^b   Pearce, E J ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; CERCARIA; GRANULOMA; HELPER CELL; HUMAN; IMMUNITY; IMMUNOMODULATION; LIFE CYCLE; LIVER FIBROSIS; MORBIDITY; MOUSE; NONHUMAN; REVIEW; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 0031770833     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(98)01317-9     Document Type: Review

References (70)

1. Wynn T.A., Cheever A.W. Cytokine regulation of granuloma formation in schistosomiasis. Curr. Opin. Immunol. 7:1995;505-511.
2. Mahmoud, A.A.F. and Wahab, M.F.A. (1990) in Tropical and Geographical Medicine (Warren, K.S. and Mahmoud, A.A.F., eds), pp 458-473, McGraw Hill.
3. Jordan, P., Webbe, G. and Sturrock, R.F. (1993) Human Schistosomiasis, CAB International.
4. Hiatt R.A.et al. Factors in the pathogenesis of acute schistosomiasis mansoni. J. Infect. Dis. 139:1979;659-666.
5. Cheever A.W.et al. Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 37:1987;85-97.
6. Cheever A.W. Schistosomiasis: infection versus disease and hypersensitivity versus immunity. Am. J. Pathol. 142:1993;699-702.
7. Mathew R.C., Boros D.L. Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced IL-2 production in Schistosoma mansoni infection. Infect. Immun. 54:1986;820-824.
8. Hernandez H.J.et al. Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur. J. Immunol. 27:1997;1170-1176.
9. Fine D.P., Buchanan R.D., Colley D.G. Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am. J. Pathol. 71:1973;193-206.
10. Doenhoff M.J.et al. Schistosoma mansoni infection in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. I. Pathogenesis. Am. J. Trop. Med. Hyg. 28:1979;260-273.
11. Byram J., Von Lichtenberg F. Altered schistosome granuloma formation in nude mice. Am. J. Trop. Med. Hyg. 26:1977;944-962.
12. Amiri P.et al. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature. 356:1992;604-606.
13. Dunne D.W., Jones F.M., Doenhoff M.J. The purification, characterization, serological activity and hepatotoxic properties of two cationic glycoproteins from Schistosoma mansoni eggs. Parasitology. 103:1991;225-236.
14. Doenhoff M.et al. Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infections: stage specificity of the reactivity of immune serum in T-cell deprived mice. Trans. R. Soc. Trop. Med. Hyg. 75:1981;41-53.
15. Pearce E.J.et al. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a helminth, Schistosoma mansoni. J. Exp. Med. 173:1991;159-165.
16. Gryzch J.M.et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1991;1322-1327.
17. Wynn T.A.et al. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1993;1430-1440.
18. Joseph A.L., Boros D.L. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J. Immunol. 151:1993;5461-5471.
19. Ritter D., McKerrow J. Intercellular adhesion molecule 1 is the major adhesion molecule expressed during schistosome granuloma formation. Infect. Immun. 64:1996;4706-4713.
20. + T helper type 1 lymphocytes. J. Immunol. 147:1991;3921-3925.
21. Wynn T.A.et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature. 376:1995;594-596.
22. Sher A.et al. An IL-12-based vaccine approach for preventing immunopathology in schistosomiasis. Ann. New York Acad. Sci. 795:1996;202-207.
23. Rezende S.et al. Mice lacking the gamma interferon receptor have an impaired granulomatous reaction to Schistosoma mansoni infection. Infect. Immun. 65:1997;3457-3461.
24. Yap G. Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni. Infect. Immun. 65:1997;2583-2586.
25. Cheever A.W.et al. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 153:1994;753-759.
26. Kaplan M.et al. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J. Immunol. 160:1998;1850-1856.
27. Metwali A.et al. The granulomatous response in murine schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J. Immunol. 157:1996;4546-4553.
28. Pearce E.J.et al. Schistosoma mansoni in IL-4 deficient mice. Int. Immunol. 8:1996;435-444.
29. Rosa Brunet L.et al. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:1997;777-785.
30. King C.L.et al. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur. J. Immunol. 26:1996;2448-2455.
31. Wynn T.et al. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159:1997;5014-5023.
32. Sher A.et al. Interleukin 5 (IL-5) is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc. Natl. Acad. Sci. U. S. A. 87:1990;61-66.
33. Flores-Villanueva P.O.et al. Recombinant IL-10 and IL-10/Fc treatment down-regulate antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol. 156:1996;3315-3320.
34. Wynn T.A.et al. IL-10 regulates liver pathology in acute murine schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J. Immunol. 160:1998;4473-4480.
35. Faulkner H.C.et al. Interleukin-9 is involved in host-protective immunity to intestinal nematode infection. Eur. J. Immunol. 27:1997;2536-2540.
36. Bancroft A.J.et al. Interleukin-12 promotes a chronic intestinal heliminth infection. Eur. J. Immunol. 27:1997;866-877.
37. Barner M.et al. Differences between IL-4R-alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in regulation of Th2 responses. Curr. Biol. 8:1998;669-672.
38. Urban J.F.et al. IL-13, IL-4R alpha and Stat 6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 8:1998;255-264.
39. Mwatha J.K.et al. High levels of TNF, soluble TNF receptors, soluble ICAM-1 and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J. Immunol. 160:1998;1992-1999.
40. Beutler B.et al. Effect of gamma-interferon on cachectin expression by mononuclear phagocytes: reversal of the lps d (endotoxin-resistant) phenotype. J. Exp. Med. 164:1986;1791-1800.
41. Henderson G.S.et al. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am. J. Pathol. 142:1993;703-714.
42. Adewusi O.I.et al. Production of TNF-α by spleen cells of mice with chronic Schistosoma mansoni infections. Am. J. Trop. Med. Hyg. 55:1996;A507.
43. Piguet P.F., Grau G.E., Vassalli P. Tumor necrosis factor and immunopathology. Immunol. Res. 10:1991;122-140.
44. Piguet P.et al. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature. 344:1990;245-257.
45. Miyazaki Y.et al. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J. Clin. Invest. 96:1995;250-259.
46. Czaja M.J.et al. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J. Cell. Biol. 108:1989;2477-2482.
47. Prakash S., Robbins P.W., Wyler D.J. Cloning and analysis of murine cDNA that encodes a fibrogenic lymphokine, fibrosin. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2154-2158.
48. + T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice. J. Immunol. 12:1979;363-367.
49. Ragheb S., Boros D.L. Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice. J. Immunol. 142:1989;3239-3246.
50. + T cell responses during infection with the helminth Schistosoma mansoni. J. Immunol. 157:1996;3046-3053.
51. Flores Villanueva P.O.et al. Macrophages from schistosomal egg granulomas induce unresponsiveness in specific cloned Th-1 lymphocytes in vitro and down-regulate schistosomal granulomatous disease in vivo. J. Immunol. 152:1994;1847-1855.
52. Flores Villanueva P.O.et al. Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. J. Immunol. 151:1993;3192-3198.
53. Flores Villanueva P.O., Reiser H., Stadecker M.J. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages. J. Immunol. 153:1994;5190-5199.
54. Bosshardt S.et al. IL-10 deficit correlates with chronic hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni. Parasite Immunol. 19:1997;347-353.
55. + T cell mediated granulamatous pathology in schistosomiasis is downregulated by a B-dependent mechanism requiring Fc receptor signalling. J. Exp. Med. 187, 619-629.
56. Kullberg M.C.et al. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J. Immunol. 148:1992;3264-3270.
57. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. U. S. A. 90:1993;948-952.
58. Chieffi P. Interrelationship between schistosomiasis and concomitant diseases. Mem. Inst. Oswaldo Cruz. 87:1992;291-296.
59. Teixeira R.et al. Pyogenic liver abscesses and acute schistosomiasis mansoni: report on 3 cases and experimental study. Trans. R. Soc. Trop. Med. Hyg. 90:1996;280-283.
60. Kloetzel K.et al. Mortality and other parameters of concomitant infections in albino mice: the Schistosoma-Toxoplasma model. Trop. Geogr. Med. 29:1977;407-410.
61. Curry A.J.et al. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J. Exp. Med. 181:1995;769-774.
62. Pereira L.M.et al. Hepatitis B virus infection in schistosomiasis mansoni. J. Med. Virol. 42:1994;203-206.
63. Gonzalez-Amaro R.et al. Induction of tumor necrosis factor. J. Exp. Med. 179:1994;841-848.
64. + cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157:1996;798-805.
65. + T cell dependent interferon-gamma mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184:1996;597-607.
66. Hunter C.A.et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:1997;3311-3316.
67. Linke A.et al. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic stage infection. Exp. Parasitol. 84:1996;253-263.
68. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
69. Clerici M., Shearer G. The Th1-Th2 hypothesis. Immunol. Today. 15:1994;571-585.
70. Remick, D.G. and Friedland, J. (1997) Cytokines in Health and Disease, Marcel Dekker.